6678 — Techno Medica Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapContrarian

Annual income statement for Techno Medica Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,332	9,811	9,040	9,699	9,368
Cost of Revenue
Gross Profit	4,355	4,498	4,454	4,817	4,630
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,800	8,484	7,413	7,837	7,721
Operating Profit	1,532	1,327	1,627	1,862	1,647
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,550	1,339	1,649	1,851	1,666
Provision for Income Taxes
Net Income After Taxes	1,098	1,000	1,153	1,281	1,151
Net Income Before Extraordinary Items
Net Income	1,098	1,000	1,153	1,281	1,151
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,098	1,000	1,153	1,281	1,151
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	127	112	134	151	137
Dividends per Share